In the future, we will investigate whether the abnormal metabolic indicators, insulin resistance, and PRL levels of co-DM patients have a deeper unexplored influence mechanism on the protective effect of aripiprazole on hyper-prolactin. Here, PRL is linked to Insulin resistance.